Supernus Pharmaceuticals buy marge
Start price
21.06.15
/
50%
€14.50
Target price
22.07.15
€18.00
Performance (%)
24.25%
End price
22.07.15
€18.02
Summary
This prediction ended on 22.07.15 with a price of €18.02. The BUY prediction by marge finished with a performance of 24.25%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Supernus Pharmaceuticals | 6.736% | 6.736% | 56.061% | 50.365% |
| iShares Core DAX® | -1,36 % | -2,16 % | 2,08 % | 52,68 % |
| iShares Nasdaq 100 | -3,70 % | -1,16 % | 32,60 % | 88,75 % |
| iShares Nikkei 225® | -2,51 % | 7,93 % | 58,27 % | 82,31 % |
| iShares S&P 500 | -1,66 % | -0,70 % | 22,96 % | 66,08 % |
Comments by marge for this prediction
In the thread Supernus Pharmaceuticals diskutieren
Supernus
Aus meinem Langfristportofolio mit den Large-cap biotechs:
1.Gilead Science (40%)
2. Amgen (15%)
3. Celgene (25%),
und den smaller-cap biotechs:
Isis Pharmaceuticals, ChemoCentryx, Acceleron,
Portola Pharmaceuticals, Cempra, Supernus mit anteiliger Gesamtgewichtung von 20%
Nachfragen zu den einzelnen Werten beantworte ich gerne.
(Vom Mitglied beendet)